drugset / Trial / NCT01652534

Efficacy Study of Amantadine to Treat Gait Dysfunction and Freezing in Parkinson's Disease

NCT01652534

Phase 3 Terminated 3 enrolled Northwestern University
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to explore the efficacy of the drug Amantadine for the treatment of freezing of gait in patients with Parkinson's Disease. The investigators hypothesize that amantadine is useful for management of freezing of gait in subjects with Parkinson's Disease.

Timeline

Start
2011-06
Primary completion
2015-05
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amantadine Unknown 100 mg Oral

Indications